Summary
Fresenius SE & Co KGaA (Fresenius) is a global health care group, which offers products and services for dialysis treatment. It provides various dialysis services through its own clinics and sells its products to other dialysis service providers. Its major products and services includes machines for hemodialysis, acute dialysis and peritoneal dialysis; solutions for infusion therapy; dialysis care services; Spectra laboratories; liver support therapy services; and provision projects and services for hospitals and other health care facilities. It also operates and manages acute care and postacute care hospitals in Germany through Helios Kliniken Group. Its major manufacturing plants are in the US, Germany, China, Sweden and Japan. Fresenius conducts operations in Asia-Pacific, Europe, Africa and the Americas. The company is headquartered in Bad Homburg, Hessen, Germany.
Fresenius SE & Co KGaA (FRE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 8
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 9
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 10
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 11
Fresenius SE & Co KGaA, Medical Devices Deals, 2011 to YTD 2017 13
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 14
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deal Details 18
Asset Purchase 18
Fresenius to Acquire Biosimilars Business from Merck for USD718.4 Million 18
Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson 20
Fresenius Medical Care Acquires Therapeutic Apheresis Assets from HemaCare 21
Sound Inpatient Physicians Acquires Certain Assets from Inpatient Specialists 22
Fresenius Completes Acquisition Of 38 Hospitals And 11 Outpatient Facilities From Rhon-Klinikum 23
Sound Inpatient Physicians Acquires Certain Assets Of Inpatient Care Unified 25
Fresenius Kabi India To Acquire Manufacturing Unit Of Goa Formulations For US$37 Million 26
APP Pharma Acquires Three Critical Care Products From Nexus Pharma 27
Fresenius Medical Care Acquires Eight Dialysis Clinics in Ecuador 28
Fresenius Medical Care Completes Acquisition Of International Dialysis Centers From Euromedic International 29
Fresenius To Acquire German Hospitals 31
Fresenius Medical Care Acquires Crit-Line System Assets From Hema Metrics 32
Venture Financing 33
Fresenius Medical Care Elgin Raises US$3 Million In Venture Financing 33
Fresenius Medical Care Palatine Raises US$3 Million In Venture Financing 34
Fresenius Medical Care Raises US$5.5 Million In Venture Financing 35
Fresenius Vascular Care Raises US$0.3 Million In Venture Financing 36
Fresenius Medical Care Batavia Raises US$1.8 Million In Venture Financing 37
Fresenius Medical Care West Raises US$2.3 Million In Venture Financing 38
Fresenius Medical Care Enid Raises US$2.4 Million In Venture Financing 39
Fresenius Medical Care Pomona To Raise US$2.56 Million In Venture Financing 40
Partnerships 41
Spectral Medical Enters into Agreement with Fresenius Medical Care Deutschland 41
CytoSorbents Enters into Distribution Agreement with Fresenius Medical Care for CytoSorb Therapy 42
Partners HealthCare to Form Joint Venture with MedSpring Urgent Care 43
Otsuka Pharma Factory Enters Into Distribution Agreement With Fresenius Kabi Japan For HES Products 44
Apollo Medical Enters Into Agreement With Fresenius Medical Care For End Stage Renal Disease 45
Heritage California Enters Into Agreement With Fresenius Medical For End Stage Renal Disease 46
Provepharm Enters Into Distribution Agreement With Fresenius Kabi Pharma 47
Huons Enters Into Co-Promotion Agreement With Fresenius Kabi For Fresofol 48
Handok Pharma Enters Into Co-Marketing Agreement With Fresenius Kabi 49
Licensing Agreements 50
Caplin Point Laboratories Enters into Licensing and Distribution Agreement with Fresenius Kabi USA 50
InnoPharma Enters Into Licensing Agreement With Fresenius Kabi For Acetylcysteine Solution 51
Toray Industries Enters Into Licensing Agreement With Fresenius Medical Care For TRK-820 52
Medicines Company Enters Into Licensing Agreement With APP For Acute Care Generic Products 53
APP Pharma Enters Into Licensing Agreement With Teva Pharma For Gemcitabine HCI 54
Equity Offering 55
Fresenius Plans Private Placement Of Shares For US$1.3 Billion 55
Debt Offering 56
Fresenius Raises USD530.4 Million in Private Placement of 3% Notes Due 2032 56
Fresenius Raises USD742.5 Million in Private Placement of 0.875% Notes Due 2022 57
Fresenius Raises USD742.5 Million in Private Placement of 1.5% Notes Due 2024 58
Fresenius Raises USD742.5 Million in Private Placement of 2.125% Notes Due 2027 59
Fresenius Raises USD300 Million in Private Placement of Notes 60
Fresenius Medical Care Raises USD518 Million in Private Placement of Convertible Bonds 61
Fresenius Increases Size Of Private Placement Of Notes Due 2024 For US$611.4 Million 62
Fresenius Completes Private Placement Of Notes Due 2019 For US$407.6 Million 63
Fresenius Completes Private Placement Of Notes Due 2021 For US$611.4 Million 64
Fresenius Medical Care Prices Private Placement Of Notes Due 2020 For US$673 Million 65
Fresenius Medical Care Completes Private Placement Of 5.625% Senior Unsecured Notes Due 2019 For US$800 Million 67
Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2019 For US$316.4 Million 68
Fresenius Medical Care Completes Private Placement Of 5.875% Senior Unsecured Notes Due 2022 For US$700 Million 69
Fresenius Medical Care Completes Private Placement Of Floating-Rate Senior Notes Due 2016 For US$133.7 Million 70
Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For US$550 Million 71
Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For US$400 Million 72
Fresenius Medical Care Completes Private Placement Of 5.75% Senior Unsecured Notes Due 2021 For US$650 Million 73
Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2021 For US$403 Million 74
Asset Transactions 75
Xellia Acquires Lyophilized Manufacturing Facility from Fresenius Kabi 75
Davita Acquires Nine Dialysis Centers From Fresenius Medical Care 76
DSI Renal Acquires 54 Dialysis Clinics From Fresenius Medical Care North America 77
Acquisition 78
Fresenius to Acquire Akorn 78
NewCo Pharma Acquires CFL from Fresenius Kabi 80
Sound Physicians Acquires Cogent Healthcare 81
Fresenius Medical Care to Acquire National Cardiovascular 82
Fresenius Kabi Acquires Novafarma Industria Farmaceutica 83
Berenberg Acquires 5% Stake in Rhoen-Klinikum from Fresenius 84
Fresenius Medical Care Acquires MedSpring Urgent Care 86
Fresenius Medical Care to Acquire Majority Stake in Sound Inpatient Physicians for USD600 Million 87
Fresenius Rumored to Withdraw Its Offer to Acquire Medical Nutrition USA from Danone 88
Fresenius Kabi To Acquire 51% Stake in Ethica Industri Farmasi From Soho Global Halthcare For US$200 Million 90
Neopharm Acquires Biotech Arm Of Fresenius 91
Fresenius Kabi (Singapore) To Delist Its Indian Arm 92
Linde To Acquire Calea France From Fresenius Kabi 93
Fresenius Kabi Completes Acquisition Of Fenwal From TPG Capital And Maverick Capital For US$1.1 Billion 94
Fresenius Acquires 70% Stake In Huangshi Lishizhen Medicine Group Wuhan Xisu Pharma From Huangshi Lishizhen Medicine Group Wuhan Lishizhen Medicine 96
Fresenius Kabi Plans To Sell 15% Stake In Fresenius Kabi Oncology 97
Fresenius Medical Care Completes Acquisition Of Liberty Dialysis Holdings For US$1.7 Billion 98
Fresenius Medical Care Acquires Eastview Dialysis 100
Fresenius Medical Care Completes Acquisition Of American Access Care Holdings For US$385 Million 101
Sound Inpatient Acquires Bay Area Inpatient 102
Fresenius SE & Co KGaA - Key Competitors 103
Fresenius SE & Co KGaA - Key Employees 104
Fresenius SE & Co KGaA - Locations And Subsidiaries 105
Head Office 105
Other Locations & Subsidiaries 105
Recent Developments 110
Strategy And Business Planning 110
Jun 08, 2017: Fresenius Medical Care sees excellent prospects for further growth and launches a new Global Efficiency Program at its Capital Markets Day 2017 110
Nov 22, 2016: HELIOS lays foundation stone for new hospital building in Wiesbaden 111
Sep 01, 2016: Fresenius Vamed completes first building phase at University Hospital Schleswig-Holstein 112
Apr 08, 2016: Fresenius Vamed lays foundation stone for new university hospital building 113
Financial Announcements 114
Aug 01, 2017: Fresenius confirms its guidance after a strong second quarter with double-digit sales and earnings growth 114
Oct 27, 2016: Fresenius: Continued strong sales and earnings growth; Lower end of Group earnings guidance raised 117
Aug 01, 2016: Fresenius Medical Care posts accelerated earnings growth in the 2nd quarter 121
May 03, 2016: Strong start into the year – Double-digit earnings growth in constant currency – Fresenius confirms Group guidance for 2016 124
Feb 24, 2016: Outstanding 2015 financial results – 25% dividend increase proposed – Positive outlook for 2016 – New mid-term growth targets 126
Corporate Communications 130
Jul 21, 2017: Fresenius appoints Rachel Empey as Chief Financial Officer 130
Jan 13, 2017: Fresenius Medical Care Announces Leadership Change in North America 131
Jun 26, 2016: Fresenius appoints Stephan Sturm as new Chief Executive Officer – Ulf Mark Schneider leaves the company to pursue another opportunity 132
Legal and Regulatory 133
Jan 31, 2017: Fresenius Medical Care reaches agreement on outstanding payments 133
Jan 26, 2017: U.S. District Court Issues Preliminary Injunction Against Premium Assistance Regulation 134
Other Significant Developments 135
Aug 22, 2017: Fresenius Helios invests in German hospital network 135
Jul 12, 2017: Fresenius Medical Care successfully amends and extends its credit agreement, ahead of schedule 136
Sep 08, 2016: Fresenius Helios expands hospital in Hildesheim 137
Aug 17, 2016: Fresenius Kabi investing nearly $250 million to expand plant near Chicago 138
Jun 08, 2016: HELIOS invests in new hospital building in Duisburg, Germany 139
Appendix 140
Methodology 140
About GlobalData 140
Contact Us 140
Disclaimer 140
List of Tables
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 8
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 9
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 10
Fresenius SE & Co KGaA, Deals By Therapy Area, 2011 to YTD 2017 11
Fresenius SE & Co KGaA, Medical Devices Deals, 2011 to YTD 2017 13
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 14
Fresenius to Acquire Biosimilars Business from Merck for USD718.4 Million 18
Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson 20
Fresenius Medical Care Acquires Therapeutic Apheresis Assets from HemaCare 21
Sound Inpatient Physicians Acquires Certain Assets from Inpatient Specialists 22
Fresenius Completes Acquisition Of 38 Hospitals And 11 Outpatient Facilities From Rhon-Klinikum 23
Sound Inpatient Physicians Acquires Certain Assets Of Inpatient Care Unified 25
Fresenius Kabi India To Acquire Manufacturing Unit Of Goa Formulations For US$37 Million 26
APP Pharma Acquires Three Critical Care Products From Nexus Pharma 27
Fresenius Medical Care Acquires Eight Dialysis Clinics in Ecuador 28
Fresenius Medical Care Completes Acquisition Of International Dialysis Centers From Euromedic International 29
Fresenius To Acquire German Hospitals 31
Fresenius Medical Care Acquires Crit-Line System Assets From Hema Metrics 32
Fresenius Medical Care Elgin Raises US$3 Million In Venture Financing 33
Fresenius Medical Care Palatine Raises US$3 Million In Venture Financing 34
Fresenius Medical Care Raises US$5.5 Million In Venture Financing 35
Fresenius Vascular Care Raises US$0.3 Million In Venture Financing 36
Fresenius Medical Care Batavia Raises US$1.8 Million In Venture Financing 37
Fresenius Medical Care West Raises US$2.3 Million In Venture Financing 38
Fresenius Medical Care Enid Raises US$2.4 Million In Venture Financing 39
Fresenius Medical Care Pomona To Raise US$2.56 Million In Venture Financing 40
Spectral Medical Enters into Agreement with Fresenius Medical Care Deutschland 41
CytoSorbents Enters into Distribution Agreement with Fresenius Medical Care for CytoSorb Therapy 42
Partners HealthCare to Form Joint Venture with MedSpring Urgent Care 43
Otsuka Pharma Factory Enters Into Distribution Agreement With Fresenius Kabi Japan For HES Products 44
Apollo Medical Enters Into Agreement With Fresenius Medical Care For End Stage Renal Disease 45
Heritage California Enters Into Agreement With Fresenius Medical For End Stage Renal Disease 46
Provepharm Enters Into Distribution Agreement With Fresenius Kabi Pharma 47
Huons Enters Into Co-Promotion Agreement With Fresenius Kabi For Fresofol 48
Handok Pharma Enters Into Co-Marketing Agreement With Fresenius Kabi 49
Caplin Point Laboratories Enters into Licensing and Distribution Agreement with Fresenius Kabi USA 50
InnoPharma Enters Into Licensing Agreement With Fresenius Kabi For Acetylcysteine Solution 51
Toray Industries Enters Into Licensing Agreement With Fresenius Medical Care For TRK-820 52
Medicines Company Enters Into Licensing Agreement With APP For Acute Care Generic Products 53
APP Pharma Enters Into Licensing Agreement With Teva Pharma For Gemcitabine HCI 54
Fresenius Plans Private Placement Of Shares For US$1.3 Billion 55
Fresenius Raises USD530.4 Million in Private Placement of 3% Notes Due 2032 56
Fresenius Raises USD742.5 Million in Private Placement of 0.875% Notes Due 2022 57
Fresenius Raises USD742.5 Million in Private Placement of 1.5% Notes Due 2024 58
Fresenius Raises USD742.5 Million in Private Placement of 2.125% Notes Due 2027 59
Fresenius Raises USD300 Million in Private Placement of Notes 60
Fresenius Medical Care Raises USD518 Million in Private Placement of Convertible Bonds 61
Fresenius Increases Size Of Private Placement Of Notes Due 2024 For US$611.4 Million 62
Fresenius Completes Private Placement Of Notes Due 2019 For US$407.6 Million 63
Fresenius Completes Private Placement Of Notes Due 2021 For US$611.4 Million 64
Fresenius Medical Care Prices Private Placement Of Notes Due 2020 For US$673 Million 65
Fresenius Medical Care Completes Private Placement Of 5.625% Senior Unsecured Notes Due 2019 For US$800 Million 67
Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2019 For US$316.4 Million 68
Fresenius Medical Care Completes Private Placement Of 5.875% Senior Unsecured Notes Due 2022 For US$700 Million 69
Fresenius Medical Care Completes Private Placement Of Floating-Rate Senior Notes Due 2016 For US$133.7 Million 70
Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For US$550 Million 71
Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For US$400 Million 72
Fresenius Medical Care Completes Private Placement Of 5.75% Senior Unsecured Notes Due 2021 For US$650 Million 73
Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2021 For US$403 Million 74
Xellia Acquires Lyophilized Manufacturing Facility from Fresenius Kabi 75
Davita Acquires Nine Dialysis Centers From Fresenius Medical Care 76
DSI Renal Acquires 54 Dialysis Clinics From Fresenius Medical Care North America 77
Fresenius to Acquire Akorn 78
NewCo Pharma Acquires CFL from Fresenius Kabi 80
Sound Physicians Acquires Cogent Healthcare 81
Fresenius Medical Care to Acquire National Cardiovascular 82
Fresenius Kabi Acquires Novafarma Industria Farmaceutica 83
Berenberg Acquires 5% Stake in Rhoen-Klinikum from Fresenius 84
Fresenius Medical Care Acquires MedSpring Urgent Care 86
Fresenius Medical Care to Acquire Majority Stake in Sound Inpatient Physicians for USD600 Million 87
Fresenius Rumored to Withdraw Its Offer to Acquire Medical Nutrition USA from Danone 88
Fresenius Kabi To Acquire 51% Stake in Ethica Industri Farmasi From Soho Global Halthcare For US$200 Million 90
Neopharm Acquires Biotech Arm Of Fresenius 91
Fresenius Kabi (Singapore) To Delist Its Indian Arm 92
Linde To Acquire Calea France From Fresenius Kabi 93
Fresenius Kabi Completes Acquisition Of Fenwal From TPG Capital And Maverick Capital For US$1.1 Billion 94
Fresenius Acquires 70% Stake In Huangshi Lishizhen Medicine Group Wuhan Xisu Pharma From Huangshi Lishizhen Medicine Group Wuhan Lishizhen Medicine 96
Fresenius Kabi Plans To Sell 15% Stake In Fresenius Kabi Oncology 97
Fresenius Medical Care Completes Acquisition Of Liberty Dialysis Holdings For US$1.7 Billion 98
Fresenius Medical Care Acquires Eastview Dialysis 100
Fresenius Medical Care Completes Acquisition Of American Access Care Holdings For US$385 Million 101
Sound Inpatient Acquires Bay Area Inpatient 102
Fresenius SE & Co KGaA, Key Competitors 103
Fresenius SE & Co KGaA, Key Employees 104
Fresenius SE & Co KGaA, Other Locations 105
Fresenius SE & Co KGaA, Subsidiaries 105
List of Figures
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2.5
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 8
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 9
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 10
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 11
Fresenius SE & Co KGaA, Medical Devices Deals, 2011 to YTD 2017 13
